Effectiveness and safety of low-dose oral minoxidil in male androgenetic alopecia Juan Jimenez-Cauhe, MD, David Saceda-Corralo, MD, PhD, Rita Rodrigues-Barata, MD, Angela Hermosa-Gelbard, MD, Oscar M. Moreno-Arrones, MD, Diego Fernandez-Nieto, MD, Sergio Vaño-Galvan, MD, PhD Journal of the American Academy of Dermatology Volume 81, Issue 2, Pages 648-649 (August 2019) DOI: 10.1016/j.jaad.2019.04.054 Copyright © 2019 American Academy of Dermatology, Inc. Terms and Conditions
Fig 1 A, Androgenetic alopecia grade II in a 28 year-old male. B, Marked improvement after 3 months of treatment with oral minoxidil, 5 mg daily, in monotherapy. Journal of the American Academy of Dermatology 2019 81, 648-649DOI: (10.1016/j.jaad.2019.04.054) Copyright © 2019 American Academy of Dermatology, Inc. Terms and Conditions